Bristol-Myers Squibb Co. (NYSE: BMY) reported Q2 EPS of $0.48, $0.04 better than the analyst estimate of $0.44. Revenue for the quarter came in at $3.89 billion versus the consensus estimate of $3.85 billion.

Bristol-Myers Squibb Co. reaffirmed FY2014 guidance.

For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.